Search hospitals > Texas > Houston
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Claim this profileHouston, Texas 77030
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Solid Tumors
Conducts research for Neuroblastoma
Conducts research for Breast Cancer
295 reported clinical trials
48 medical researchers
Summary
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center is a medical facility located in Houston, Texas. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Neuroblastoma, Breast Cancer and other specialties. Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center is involved with conducting 295 clinical trials across 461 conditions. There are 48 research doctors associated with this hospital, such as Jennifer Foster, MD, Patricia Baxter, MD, Mothaffar Rimawi, MD, and Ahmed Elkhanany.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage IV
BRAF positive
Stage II
Top PIs
Jennifer Foster, MDBaylor College of Medicine/Dan L Duncan Comprehensive Cancer Center3 years of reported clinical research
Expert in Neuroblastoma
Expert in Cancer
34 reported clinical trials
53 drugs studied
Patricia Baxter, MDTexas Children's Hospital3 years of reported clinical research
Expert in Brain Tumor
Expert in Diffuse Intrinsic Pontine Glioma
32 reported clinical trials
40 drugs studied
Mothaffar Rimawi, MDBaylor College of Medicine6 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
23 drugs studied
Ahmed ElkhananyUniversity of Alabama at Birmingham Cancer Center2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
26 drugs studied
Clinical Trials running at Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Cancer
Lung Cancer
Breast Cancer
Bladder Cancer
Brain Tumor
Breast cancer
Testicular cancer
Prostate Cancer
Brain Cancer
Wilms Tumor
Cooling/Compression Therapy
for Chemotherapy-Induced Peripheral Neuropathy
This trial tests three methods to prevent nerve damage in patients receiving taxane chemotherapy. The methods involve using special wraps that either cool the limbs, apply steady pressure, or apply gentle pressure that comes and goes. These approaches aim to protect nerves from the harmful effects of chemotherapy drugs. Cooling the limbs has been well-tolerated and is a reasonable option to prevent nerve damage in patients receiving taxane-based treatments.
Recruiting2 awards Phase 3
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center?
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center is a medical facility located in Houston, Texas. This center is recognized for care of Cancer, Brain Tumor, Solid Tumors, Neuroblastoma, Breast Cancer and other specialties. Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center is involved with conducting 295 clinical trials across 461 conditions. There are 48 research doctors associated with this hospital, such as Jennifer Foster, MD, Patricia Baxter, MD, Mothaffar Rimawi, MD, and Ahmed Elkhanany.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.